0024

COM:JIUAN

九安医疗

  • Stock

Last Close

45.59

22/11 07:04

Market Cap

18.74B

Beta: -

Volume Today

7.49M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
167.55M
-
238.53M
42.36%
271.51M
13.83%
252.25M
7.09%
218.99M
13.19%
221.55M
1.17%
218.00M
1.61%
238.98M
9.63%
454.54M
90.20%
662.72M
45.80%
490.25M
26.02%
average payables
46.93M
-
67.09M
42.94%
55.90M
16.69%
32.70M
41.50%
42.18M
29.00%
64.86M
53.74%
78.35M
20.80%
109.17M
39.34%
165.21M
51.33%
251.48M
52.21%
208.17M
17.22%
average receivables
121.88M
-
133.93M
9.88%
117.78M
12.06%
151.78M
28.86%
172.04M
13.35%
167.20M
2.81%
164.50M
1.61%
158.87M
3.43%
513.22M
223.05%
692.98M
35.03%
390.79M
43.61%
book value per share
1.63
-
2.23
36.86%
1.66
25.81%
4.25
156.84%
3.14
26.25%
3.65
16.30%
3.75
2.88%
4.35
16.04%
6.32
45.12%
42.86
578.25%
42.97
0.25%
capex per share
-0.13
-
-0.17
30.12%
-0.09
50.05%
-0.19
123.52%
-0.13
32.61%
-0.42
228.26%
-0.14
67.73%
-0.12
9.40%
-0.15
24.75%
-0.46
199.71%
-0.48
2.30%
capex to depreciation
-5.68
-
-2.81
50.44%
-1.28
54.54%
-1.99
55.42%
-1.21
39.29%
-3.27
170.75%
-1.02
68.78%
-0.86
16.07%
-0.79
7.96%
-2.00
153.46%
-1.98
1.11%
capex to operating cash flow
0.81
-
0.85
4.25%
0.24
71.24%
1.91
681.62%
0.61
67.77%
1.72
180.54%
1.39
19.41%
-0.12
108.38%
-0.24
106.34%
-0.01
95.16%
-0.11
806.37%
capex to revenue
-0.15
-
-0.14
7.57%
-0.08
42.22%
-0.17
108.64%
-0.09
42.98%
-0.32
237.25%
-0.09
73.01%
-0.03
68.87%
-0.03
9.77%
-0.01
72.60%
-0.07
728.81%
cash per share
0.74
-
0.35
53.05%
0.33
4.27%
2.18
557.84%
1.50
31.32%
1.04
30.38%
1.65
58.23%
2.78
68.22%
2.96
6.32%
25.18
752.04%
25.44
1.02%
days of inventory on hand
271.56
-
340.13
25.25%
333.85
1.84%
300.56
9.97%
179.31
40.34%
221.15
23.34%
142.75
35.45%
116.99
18.05%
261.73
123.71%
47.44
81.87%
83.39
75.77%
days payables outstanding
73.54
-
98.34
33.72%
40.70
58.61%
41.65
2.34%
45.68
9.67%
71.89
57.39%
57.26
20.35%
58.00
1.29%
79.62
37.27%
21.22
73.35%
30.77
45.02%
days sales outstanding
114.97
-
119.67
4.09%
88.14
26.34%
180.25
104.50%
83.38
53.74%
128.04
53.56%
67.80
47.05%
33.90
50.00%
127.89
277.24%
7.57
94.08%
26.98
256.22%
debt to assets
0.10
-
0.10
0.89%
0.06
41.30%
0.19
215.94%
0.17
9.85%
0.12
31.93%
0.10
12.14%
0.15
47.70%
0.10
36.13%
0.01
84.87%
0.07
371.39%
debt to equity
0.13
-
0.14
4.81%
0.08
40.18%
0.29
258.65%
0.26
9.61%
0.14
45.06%
0.12
17.10%
0.20
65.09%
0.13
33.01%
0.02
87.71%
0.08
398.95%
dividend yield
0.00
-
0.00
226.77%
0.00
128.44%
0.00
25.58%
0.00
243.27%
0.00
7.73%
0.00
30.47%
0.00
56.71%
0.00
2.53%
0.01
748.15%
0.07
405.72%
earnings yield
-0.00
-
0.00
172.03%
-0.02
1,369.84%
0.00
115.52%
-0.04
1,713.75%
0.01
114.31%
0.01
102.09%
0.06
404.49%
0.04
33.49%
0.69
1,604.14%
0.07
89.20%
enterprise value
4.81B
-
7.79B
61.88%
9.01B
15.72%
5.32B
40.93%
3.70B
30.57%
1.92B
48.14%
2.12B
10.51%
3.45B
63.04%
22.01B
537.31%
18.19B
17.34%
16.19B
11.01%
enterprise value over ebitda
438.15
-
159.78
63.53%
-75.74
147.40%
102.30
235.07%
-42.09
141.14%
11.98
128.46%
-25.38
311.83%
4.11
116.19%
19.89
384.23%
0.96
95.20%
18.89
1,876.27%
ev to operating cash flow
-64.59
-
-112.97
74.91%
-69.59
38.40%
-145.82
109.55%
-40.21
72.42%
-18.40
54.25%
-48.47
163.48%
7.48
115.43%
75.08
903.69%
1.00
98.67%
8.02
703.68%
ev to sales
11.80
-
18.30
55.08%
22.65
23.74%
12.67
44.06%
6.18
51.21%
3.40
45.01%
3.00
11.77%
1.72
42.66%
9.18
433.96%
0.69
92.47%
5.08
634.92%
free cash flow per share
-0.29
-
-0.37
27.20%
-0.44
16.86%
-0.29
33.16%
-0.34
16.12%
-0.67
97.45%
-0.24
64.88%
0.94
499.72%
0.49
48.02%
39.48
7,958.81%
4.03
89.78%
free cash flow yield
-0.03
-
-0.02
38.92%
-0.02
8.58%
-0.02
6.31%
-0.04
97.25%
-0.13
258.01%
-0.05
65.14%
0.10
320.00%
0.01
90.32%
0.77
7,712.84%
0.11
86.14%
graham net net
0.77
-
0.34
55.72%
0.32
4.97%
0.69
114.03%
0.30
56.77%
0.78
160.15%
1.33
70.99%
1.96
47.78%
2.62
34.03%
23.10
780.24%
19.93
13.73%
graham number
0.86
-
1.23
43.28%
3.91
218.42%
1.96
49.94%
5.18
164.69%
1.57
69.70%
2.27
44.73%
7.41
226.13%
16.86
127.62%
184.09
991.89%
52.00
71.75%
income quality
8.72
-
-8.21
194.17%
0.86
110.46%
-2.52
393.12%
0.55
122.01%
36.43
6,476.79%
-1.61
104.43%
1.95
220.71%
0.31
83.91%
1.11
252.39%
1.61
45.83%
intangibles to total assets
0.08
-
0.08
4.98%
0.10
25.78%
0.26
166.93%
0.32
21.71%
0.32
0.13%
0.27
15.39%
0.16
40.65%
0.10
38.61%
0.01
88.56%
0.00
63.19%
interest coverage
-8.68
-
4.95
157.00%
-84.91
1,816.77%
1.70
102.00%
-14.98
980.87%
-13.26
11.48%
-18.10
36.55%
111.89
718.08%
75.39
32.62%
3.85K
5,009.97%
49.21
98.72%
interest debt per share
0.21
-
0.31
47.29%
0.14
55.77%
1.25
798.22%
0.85
31.95%
0.54
36.15%
0.47
13.86%
0.88
87.36%
0.86
1.23%
0.71
18.26%
3.52
397.62%
inventory turnover
1.34
-
1.07
20.16%
1.09
1.88%
1.21
11.07%
2.04
67.63%
1.65
18.92%
2.56
54.92%
3.12
22.02%
1.39
55.30%
7.69
451.68%
4.38
43.11%
invested capital
0.13
-
0.14
4.81%
0.08
40.18%
0.29
258.65%
0.26
9.61%
0.14
45.06%
0.12
17.10%
0.20
65.09%
0.13
33.01%
0.02
87.71%
0.08
398.95%
market cap
5.05B
-
7.80B
54.42%
9.08B
16.43%
5.63B
38.03%
3.99B
29.11%
2.13B
46.57%
2.25B
5.54%
3.99B
77.52%
22.52B
463.80%
23.32B
3.52%
16.86B
27.70%
net current asset value
488.62M
-
453.03M
7.28%
284.51M
37.20%
678.61M
138.52%
410.66M
39.48%
509.82M
24.15%
721.94M
41.61%
1.04B
43.94%
1.76B
69.82%
11.49B
551.04%
9.21B
19.87%
net debt to ebitda
-22.05
-
-0.31
98.59%
0.61
296.37%
-5.90
1,064.30%
3.36
157.00%
-1.35
140.11%
1.59
217.68%
-0.64
140.59%
-0.47
27.66%
-0.27
42.23%
-0.78
190.74%
net income per share
-0.02
-
0.03
250.00%
-0.41
1,466.67%
0.04
109.76%
-0.38
1,050.00%
0.03
107.89%
0.06
103.61%
0.56
816.62%
2.00
257.03%
35.14
1,657.79%
2.80
92.04%
operating cash flow per share
-0.16
-
-0.20
24.81%
-0.35
73.65%
-0.10
71.40%
-0.21
109.08%
-0.25
17.01%
-0.10
59.96%
1.07
1,181.35%
0.64
39.54%
39.94
6,094.03%
4.51
88.71%
payables turnover
4.96
-
3.71
25.22%
8.97
141.63%
8.76
2.29%
7.99
8.82%
5.08
36.47%
6.37
25.55%
6.29
1.27%
4.58
27.15%
17.20
275.28%
11.86
31.05%
receivables turnover
3.17
-
3.05
3.93%
4.14
35.77%
2.02
51.10%
4.38
116.17%
2.85
34.88%
5.38
88.85%
10.77
100.00%
2.85
73.49%
48.19
1,588.55%
13.53
71.93%
research and ddevelopement to revenue
0.02
-
0.02
3.14%
0.11
410.45%
0.10
10.04%
0.16
59.40%
0.12
22.37%
0.11
7.21%
0.04
66.37%
0.03
26.96%
0.01
63.84%
0.08
722.13%
return on tangible assets
-0.01
-
0.01
204.07%
-0.20
1,948.39%
0.01
104.10%
-0.12
1,493.62%
0.01
108.42%
0.02
95.45%
0.12
513.24%
0.26
118.27%
0.75
190.67%
0.06
92.55%
revenue per share
0.89
-
1.25
40.78%
1.08
13.55%
1.16
7.13%
1.37
18.18%
1.33
2.66%
1.59
19.57%
4.64
191.05%
5.27
13.65%
57.68
993.82%
7.12
87.66%
roe
-0.01
-
0.01
209.60%
-0.25
1,942.12%
0.01
103.80%
-0.12
1,388.17%
0.01
106.79%
0.02
97.92%
0.13
689.95%
0.32
146.02%
0.82
159.16%
0.07
92.06%
roic
-0.01
-
0.02
233.68%
-0.23
1,249.74%
0.00
102.07%
-0.10
2,300.35%
-0.03
71.07%
-0.12
291.44%
0.34
387.98%
0.29
16.25%
0.83
191.36%
0.03
96.29%
sales general and administrative to revenue
0.04
-
0.07
83.57%
0.08
23.69%
0.12
47.78%
0.10
14.90%
0.10
4.44%
0.10
0.79%
0.03
65.93%
0.04
24.74%
0.02
51.87%
shareholders equity per share
1.63
-
2.23
36.86%
1.66
25.81%
4.25
156.84%
3.14
26.25%
3.65
16.30%
3.75
2.88%
4.35
16.04%
6.32
45.12%
42.86
578.25%
42.97
0.25%
stock based compensation to revenue
tangible asset value
677.64M
-
679.76M
0.31%
527.69M
22.37%
918.28M
74.02%
693.45M
24.48%
911.03M
31.38%
1.07B
17.36%
1.42B
33.22%
2.45B
71.69%
19.78B
708.73%
19.74B
0.17%
tangible book value per share
1.48
-
2.00
35.28%
1.44
28.24%
2.53
76.55%
1.59
37.29%
2.15
35.60%
2.41
12.04%
3.29
36.35%
5.38
63.48%
43.35
705.80%
44.33
2.25%
working capital
488.62M
-
456.13M
6.65%
290.15M
36.39%
998.25M
244.05%
423.65M
57.56%
587.99M
38.79%
923.43M
57.05%
1.18B
27.36%
1.82B
54.83%
12.40B
580.75%
10.47B
15.54%

All numbers in (except ratios and percentages)